+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Adrucil"

From
Colorectal Cancer Market Forecast (2020-2025) - Product Thumbnail Image

Colorectal Cancer Market Forecast (2020-2025)

  • Report
  • August 2020
  • 113 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Adrucil (Fluorouracil) is a chemotherapy drug used in the treatment of various types of cancer. It is a pyrimidine analog, which works by interfering with the growth of cancer cells. Adrucil is used in combination with other drugs to treat a variety of cancers, including breast, colon, rectal, stomach, pancreatic, and head and neck cancers. It is also used to treat certain types of leukemia. Adrucil is administered intravenously or topically, depending on the type of cancer being treated. Adrucil is a widely used chemotherapy drug in the oncology market. It is used in combination with other drugs to treat a variety of cancers, and is administered intravenously or topically. Adrucil is a generic drug, and is available in both brand name and generic formulations. Some companies in the Adrucil market include Bristol-Myers Squibb, Pfizer, Merck, and Teva Pharmaceuticals. Show Less Read more